This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Jun 10:346:f3750.

doi: 10.1136/bmj.f3750.

Incretins and risk of neoplasia

Thorvardur R Halfdanarson¹, Rahul Pannala

Affiliations

PMID: 23751908
DOI: 10.1136/bmj.f3750

Incretins and risk of neoplasia

Thorvardur R Halfdanarson et al. BMJ. 2013.

. 2013 Jun 10:346:f3750.

doi: 10.1136/bmj.f3750.

Authors

Thorvardur R Halfdanarson¹, Rahul Pannala

Affiliation

¹ Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA. thorvardur.halfdanarson@mayo.edu

PMID: 23751908
DOI: 10.1136/bmj.f3750

No abstract available

PubMed Disclaimer

Similar articles

Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation.
Kmietowicz Z. Kmietowicz Z. BMJ. 2013 Jun 11;346:f3782. doi: 10.1136/bmj.f3782. BMJ. 2013. PMID: 23757752 No abstract available.
Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C. Egan AG, et al. N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078. N Engl J Med. 2014. PMID: 24571751 No abstract available.
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.
Nauck MA, Meier JJ, Schmidt WE. Nauck MA, et al. Diabetes Obes Metab. 2017 Sep;19(9):1327-1328. doi: 10.1111/dom.12981. Epub 2017 May 22. Diabetes Obes Metab. 2017. PMID: 28432752 No abstract available.
[Incretin-based antidiabetic treatment and diseases of the pancreas (pancreatitis, pancreas carcinoma)].
Jermendy G. Jermendy G. Orv Hetil. 2016 Apr 3;157(14):523-8. doi: 10.1556/650.2016.30409. Orv Hetil. 2016. PMID: 27017851 Review. Hungarian.
Targeting the incretin system in type 2 diabetes mellitus.
Potenza M, Rayfield EJ. Potenza M, et al. Mt Sinai J Med. 2009 Jun;76(3):244-56. doi: 10.1002/msj.20112. Mt Sinai J Med. 2009. PMID: 19421968 Review.

See all similar articles

Cited by

An Atypical Presentation of Dulaglutide-Induced Pancreatitis Complicated by Superior Mesenteric Vein Thrombosis.
Manuel SL, Lin F, Kutty SM. Manuel SL, et al. Cureus. 2023 Dec 6;15(12):e50051. doi: 10.7759/cureus.50051. eCollection 2023 Dec. Cureus. 2023. PMID: 38186519 Free PMC article.
Drug-induced pancreatitis: a real-world analysis of the FDA Adverse Event Reporting System and network pharmacology.
Xie H, Jiang L, Peng J, Hu H, Han M, Zhao B. Xie H, et al. Front Pharmacol. 2025 Apr 16;16:1564127. doi: 10.3389/fphar.2025.1564127. eCollection 2025. Front Pharmacol. 2025. PMID: 40308779 Free PMC article.
Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.
Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, Rios LP, Malaga G, Wong E, Sohani Z, Guyatt GH, Sun X. Li L, et al. BMJ. 2014 Apr 15;348:g2366. doi: 10.1136/bmj.g2366. BMJ. 2014. PMID: 24736555 Free PMC article.
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss.
Modestino EJ, Bowirrat A, Lewandrowski KU, Sharafshah A, Badgaiyan RD, Thanos PK, Baron D, Dennen CA, Elman I, Sunder K, Murphy KT, Blum K. Modestino EJ, et al. Acta Sci Neurol. 2024 May;7(5):12-18. doi: 10.31080/asne.2024.07.0731. Epub 2024 Apr 19. Acta Sci Neurol. 2024. PMID: 39118673 Free PMC article.
Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials.
Chen H, Zhou X, Chen T, Liu B, Jin W, Gu H, Hong T, Zhang G. Chen H, et al. Diabetes Ther. 2016 Dec;7(4):725-742. doi: 10.1007/s13300-016-0198-3. Epub 2016 Sep 21. Diabetes Ther. 2016. PMID: 27655330 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information